Stanford University at CTAD 2026
Nov 16–19, 2026 Boston, MA ~1.7k attendees Website
Stanford University takes part in 10 sessions at CTAD 2026 in Boston. Its program ranges from late-stage drug trials to population studies of shingles vaccination and dementia risk. Its work covers the POLARIS-AD phase 3 results, CSF tau changes with LM11A-31, cellular senescence signatures and high-frequency monitoring of cognition.
| Organization | CTAD 2026 Attendance |
|---|---|
Stanford University Stanford, California | |
Runs the Stanford Alzheimer's Disease Research Center, studying biomarkers, imaging and cognitive ageing. | Poster Mon Nov 16 – Tue Nov 17 2:00pm Mon – 5:30pm Tue Poster Mon Nov 16 – Tue Nov 17 2:00pm Mon – 5:30pm Tue Poster Mon Nov 16 – Tue Nov 17 2:00pm Mon – 5:30pm Tue Talk Mon Nov 16 4:05pm Talk Tue Nov 17 3:45pm Talk Wed Nov 18 1:55pm Poster Thu Nov 19 7:15am–5:00pm Poster Thu Nov 19 7:15am–5:00pm Poster Thu Nov 19 7:15am–5:00pm |
Instantly find 20 buyers from Stanford University
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the CTAD Conference. Organization details are derived from CTAD’s published program, poster list and sponsor page. Submit a correction